Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,540 signal articles · 31 in last 24h · 122,378 total before filter · latest 1h ago
31last 24h
1250last 7d
210● bullish (7d)
149● bearish (7d)
205publishers
AllMacro210Earnings430M&A97Regulatory24Product9Analyst10
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Agnico Eagle Mines (AEM) Is Up 20.7% After EPS Jumps Despite Lower Gold Output And Buybacks
Simply Wall St.11d agobullish
Agnico Eagle Mines (AEM) Is Up 20.7% After EPS Jumps Despite Lower Gold Output And Buybacks

In late July 2026, Agnico Eagle Mines reported second-quarter results showing slightly lower gold production year over year but a sharp increase in net income and earnings per share, while also guiding full-year 2026 output toward the lower end of its 3.3–3.5 million-ounce range and maintaining its quarterly dividend at US$0.45 per share. The company paired this earnings jump with a completed US$377.48 million share repurchase of 2,110,462 shares and ongoing project updates, signaling a...

Why Is Nasdaq (NDAQ) Supplying Surveillance Tech To A Prediction Markets Operator?
Simply Wall St.11d agoneutral
Why Is Nasdaq (NDAQ) Supplying Surveillance Tech To A Prediction Markets Operator?

Nasdaq (NasdaqGS:NDAQ) has entered a multi-year agreement to supply its market surveillance technology to prediction markets operator Kalshi. The partnership focuses on monitoring trading activity for potential insider trading and market manipulation on Kalshi's platforms. The deal extends Nasdaq's role as a technology and compliance infrastructure provider to newer types of financial markets. Consider exploring other established exchange and market infrastructure stocks that could offer a...

What Could Push AMZN Stock Higher From Here?
Trefis11d agoneutral
What Could Push AMZN Stock Higher From Here?

Beyond the familiar retail storefront, a massive custom silicon operation is quietly compounding. This internal chips business now has an annual revenue run rate of over twenty-five billion dollars. The company's AI services have also crossed this threshold, creating two new growth engines inside the larger machine.

Is SpaceX Worth More Than Earth?
TheStreet11d agoneutral
Is SpaceX Worth More Than Earth?

How do you value the assets of about 8.3 billion people and a livable planet that is 4.54 billion years old – give or take 50 million years? The question came up in an Elon Musk tweet on July 9: “SpaceX will be worth more than the rest of Earth if we accomplish our goals.” – Elon Musk The key ...

Factorial Energy Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Factorial Energy Q2 Earnings Call Highlights

Factorial Energy (NASDAQ:FAC) outlined its path toward initial commercial revenue in 2027 during its inaugural earnings call as a public company, citing a first commercial drone-battery order, progress in flight testing and automotive integration, and a capital-light manufacturing strategy. Chief E

DoubleDown Interactive Q2 Earnings Call Highlights
MarketBeat11d agoneutral
DoubleDown Interactive Q2 Earnings Call Highlights

DoubleDown Interactive (NASDAQ:DDI) reported second-quarter 2026 revenue of $94.3 million, up approximately 11% from a year earlier, as growth in its social casino and iGaming operations supported higher profitability and operating cash flow. Adjusted EBITDA rose 17% year over year to $39.3 million

Astronics Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Astronics Q2 Earnings Call Highlights

Astronics (NASDAQ:ATRO) reported record second-quarter 2026 revenue, bookings, backlog and operating profit, citing stronger aerospace demand, production efficiencies and pricing actions. The company raised its full-year revenue outlook to a range of $1.02 billion to $1.04 billion, positioning it to

Absci Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Absci Q2 Earnings Call Highlights

Absci (NASDAQ:ABSI) outlined progress in its clinical program for ABS-201, a prolactin receptor-targeting antibody being studied for pattern hair loss and planned for development in endometriosis, while reporting a larger cash balance following a June equity offering and strategic investment from El